Status:
UNKNOWN
A Prospective Randomized Multicentre Study to Compare Crinone 8% Once Daily Versus Other Vaginal Progesterone.
Lead Sponsor:
Nordica Fertility Clinic
Collaborating Sponsors:
Merck Serono International SA
Conditions:
IVF - Luteal Phase Support After Embryo Transfer
Eligibility:
FEMALE
18-40 years
Phase:
PHASE4
Brief Summary
To compare the effect of Crinone 8% administered once daily versus other vaginal progesterone in terms of ongoing pregnancy rate 5 weeks after embryo transfer as well as patient convenience.
Eligibility Criteria
Inclusion
- 18-40 years
- Regular menstrual cyclus 25-35 days
- both ovaries present
- No more than 2 previous IVF attempts
- Have given written informed consent
Exclusion
- More than 2 previous attempts
- Known drug abuse
- Known allergies to the study medication
- No embryo transfer performed in the study cycle
- Previous participating in the study
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
2686 Patients enrolled
Trial Details
Trial ID
NCT00708539
Start Date
April 1 2006
End Date
December 1 2008
Last Update
July 2 2008
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Faurskov fertility clinic
Aalborg, Denmark, 9000
2
Brædstrup Sygehus
Brædstrup, Denmark, 8740
3
Dronninglund sygehus
Dronninglund, Denmark, 9330
4
Dansk Fertilitetsklinik
Frederiksberg, Denmark, 2000